Reynders Mc Veigh Capital Management, LLC Moderna, Inc. Transaction History
Reynders Mc Veigh Capital Management, LLC
- $1.76 Billion
- Q2 2024
A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 13,670 shares of MRNA stock, worth $834,963. This represents 0.09% of its overall portfolio holdings.
Number of Shares
13,670
Previous 13,052
4.73%
Holding current value
$834,963
Previous $1.39 Million
16.68%
% of portfolio
0.09%
Previous 0.08%
Shares
11 transactions
Others Institutions Holding MRNA
# of Institutions
1,113Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.65 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.42 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.56 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$918 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$441 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $23.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...